Hi-Tech Pharmaceuticals has been in the supplement industry for decades, operating as both a manufacturer for countless partners and the owner of a long list of consumer-facing brands. Its catalog and contract production reach have made it a recognizable name in many areas of the market. That longstanding presence is precisely what makes the latest development so significant, as the company and its CEO, Jared Wheat, have now found themselves at the center of a federal trial.
A six-week trial has detailed how Hi-Tech falsified documents to convince customers it met federally required Good Manufacturing Practices, despite a 2010 third-party audit identifying severe failures across 75 categories, including contamination risks, improper facility conditions, and critical testing gaps. Instead of correcting those issues, the company fabricated a GMP certificate under a shell entity it secretly controlled, forged signatures, and altered the original audit report to show compliance.
Prosecutors further established that Hi-Tech repeatedly used these fabricated GMP certificates and falsified FDA export documents between 2011 and 2013 to secure international approvals and customer trust, ultimately bringing in at least $4.76 million from the scheme. The jury found the company guilty of wire fraud and money laundering, with potential penalties reaching nearly $10 million, while CEO Jared Wheat faces up to 20 years in prison, with sentencing to be scheduled.
